Research
Priorities

Breakthrough Cancer Research (BCR) is a leading Irish medical research charity funding game-changing cancer research.

This year, we are funding world-class research projects to, develop new ways to treat cancer, improve quality of life for cancer patients, improve treatment outcomes and ultimately – save more lives.

9,000 Irish men, women and children women still lose their life to cancer every year. But with your continued support, our researchers are determined to dramatically reduce this number.

Together, we will save the people who cannot be saved today.

  • All
  • Detection
  • Policy
  • Prevention
  • Survivorship
  • Treatment
Utilising proteomics-derived data in establishing predictive biomarker
Estimating Costs, Resource Use and Financial Toxicity Amongst Cancer P
Getting a Handle on Non-Canonical Polycomb Repressor Complex 1 (nc-PRC
Investigation of novel drugs in Chemotherapy-resistant Ovarian Cancer
Patients’ Access to Advanced Cancer Therapies: Ethics and Equity of Ac
The utility of exhaled breath condensate to detect sub-clonal mutation
Scoping Research for a Digital Platform Connecting Irish Cancer Inform
Breakthrough Cancer Nutrition
Targeting the anti-apoptotic BCL-2 dependence in Multiple Myeloma
Assess immune response to neoadjuvant treatment in oesophagogastric ad
Acid-stimulated Ca2+ signals as a potential therapeutic target for the
investigate the role of cysteinyl leukotriene (CysLT) receptors in Uve
Women’s Cancer Survivorship: Supporting and Innovating for Change
Evaluation of Electrochemotherapy to Improve Patient Quality of Life a
Evaluating anti-neoplastic activity of HDAC6 inhibitors in uveal melan
Evaluation of the Therapeutic and Adverse Potential Cannabinoids in vi
Precision Oncology Ireland
Infrastructure grant: LI-COR Odessey CLx Infra red Imaging system
Living and Dying Well – An Investigation of the Psychosocial and Spiri
The EVeCanS Study
Osteosarcoma Combination of Electroporation of Metabolic Modulators wi
Epigenetic modulating compounds as potential therapeutic agents for oe
Role of Autophagy in Differentiation Therapy in AML
Role of Autophagy in Progression of Oesophageal Cancer
The role of diet, nutritional assessment and intervention in the preve
Bacteria in Human Tumours
Ovarian Research Fellowship Announced
Gold-drug: Targeting a novel dual inhibitor drug with gold nanoparticl
Evaluation of a Mindfulness Based Stress Reduction programme on the qu
Evaluation of the role of MxA and ISGylation in chemosensitivity in oe
Combining electrochemotherapy with a Toll Like receptor agonist for th
Contribution of diet and lifestyle factors and metabolic phenotype to
Nutrition and cancer: what is the information experience?
Enhancing electroporation delivery for pancreatic cancer
Effect of a novel drug and electroporation on melanoma and intratumour
Harnessing the power of the immune system to fight obesity associated
Epigenetic modulating compounds as potential adjunct therapeutic agent
Involving Men with PROstate cancer in Engaged Research
Radiation Response in Oesophageal Cancer: the role of visceral fat tis
Role of regulatory B cells in response to immunotherapy in advance can
Investigator Led Trials on the Horizon for Pancreatic Cancer
Infrastructure Grant: Cold Plate for Tissue Microtomy
Electroporation for Skin Cancer Treatment
Investigation into the role of autophagy in the recurrence of Ovarian
Measuring genetic markers in the blood of patients with small cell lun
Investigation of new biomarkers of treatment response in glioblastoma
Precision Oncology Ireland
Effect of bacterial membrane vesicles (BMVs) released by human gut mic
Developing personalised therapies for Uveal Melanoma
Investigating chemotherapy-resistant ovarian cancer

LATEST NEWS